When Is a Unicorn Really Worth $1 Billion?
In an era of ambitious startup valuations, it’s important to remember how difficult it is to grow and sustain a viable ‘unicorn’ – a company…
Posted by
In an era of ambitious startup valuations, it’s important to remember how difficult it is to grow and sustain a viable ‘unicorn’ – a company…
Posted by
In February 2011—long before the term “Internet of Things” became a hot business buzzword—Safeguard Scientifics saw potential in ThingWorx, the first application platform that lets…
Posted by
When Stephen T. Zarrilli joined Safeguard in 2008, the company was in the midst of an effort to rebuild its brand and reputation in the…
Posted by
The convergence of technology and healthcare attracted significant new attention last year, according to research from Dow Jones VentureSource. In 2011, VCs poured $439 million…
Posted by
The first quarter of 2012 has come and gone, leaving positive signs for venture capitalists. Twenty venture-backed start-ups made their IPO in the past three…
Posted by
The same technologies driving Enterprise 3.0 have also been revolutionizing health management. This convergence of technology and healthcare has built up momentum recently through new…
Posted by
As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While…
Posted by
Last week our own Gary J. Kurtzman, MD, Senior Vice President and Managing Director in the Safeguard Life Sciences Group, participated on a panel at…
Posted by
Safeguard Scientifics will commemorate its 40th anniversary of trading on the New York Stock Exchange (NYSE) by ringing today’s Closing Bell. Safeguard started trading on…
Posted by